Biotechnology · Healthcare
Board Member
2023-01-01–present
Board Member
Capricor Therapeutics, Inc. (CAPR)Equibles does not estimate personal net worth.
Paul Auwaerter is recorded as Board Member at Capricor Therapeutics, Inc. (CAPR) since January 1, 2023. The newest filing on record that lists Paul Auwaerter as Board Member at Capricor Therapeutics, Inc. (CAPR) is dated April 10, 2026. Capricor Therapeutics, Inc. reported in an 8-K filed July 13, 2023 that Paul Auwaerter was appointed member of the Board, effective July 11, 2023. Capricor Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Capricor Therapeutics, Inc. includes Linda Marban (CEO and Board Member), Frank Litvack (Chairman and Board Member), Anthony "A.J." Bergmann (CFO) and 7 others.
“On July 11, 2023, the Board elected Paul Auwaerter, M.D. as a member of the Board, effective immediately.”
2023-01-01–present
Last confirmed April 10, 2026
Biotechnology · Healthcare
Board Member
2023-01-01–present